Search

A 44-year-old man in Saudi Arabia experienced transient global amnesia (TGA) and post-COVID-19 vaccination syndrome (PCVS) after receiving the tozinameran (Pfizer COVID-19) vaccine. He had received the AstraZeneca vaccine six months prior without any adverse effects. After receiving the tozinameran vaccine, he developed fever, took paracetamol, and then became disoriented, had seizures, and lost consciousness. He was admitted to the hospital, where his tests and evaluations were normal. After a few days, he gradually regained his memory and was discharged with full recovery. The man was diagnosed with TGA and PCVS related to the tozinameran vaccine. [Extracted from the article]

IV sedation was maintained with dexmedetomidine 0.2 µg/kg/h and fentanyl 50 µg. He was administered IV acetaminophen along with lidocaine and epinephrine for postoperative analgesia. During loading, he received lidocaine spray and lidocaine jelly applied to his tongue, and IV fentanyl 25 µg was administered. [Extracted from the article]

B Author Information b An event is serious (based on the ICH definition) when the patient outcome is: * death * life-threatening * hospitalisation * disability * congenital anomaly * other medically important event A 60-year-old man developed transient global amnesia during treatment with simvastatin for dyslipidemia. A diagnosis of transient global amnesia secondary to simvastatin was made [ I time to reaction onset not stated i ]. [Extracted from the article]

Then, he underwent a contrast-less brain tomography, and it showed presence of subaracnoid hyperdensities in both occipital lobes. B Author Information b An event is serious (based on the ICH definition) when the patient outcome is: * death * life-threatening * hospitalisation * disability * congenital anomaly * other medically important event A 63-year-old man developed cortex blindness and global amnesia following administration with iopamidol during arteriography. Transient cortex blindness and global amnesia after performing left arm arteriography using iopamidol. [Extracted from the article]

B Author Information b An event is serious (based on the ICH definition) when the patient outcome is: * death * life-threatening * hospitalisation * disability * congenital anomaly * other medically important event A 67-year-old woman developed amnesia, change in character and toxic encephalopathy during treatment with paclitaxel, trastuzumab and pertuzumab for breast carcinoma. The woman underwent resection of breast carcinoma on the right side following which a port catheter was implanted on the left side epipectoral for adjuvant chemotherapy with intra-arterial administration of paclitaxel, pertuzumab and trastuzumab [ I dosages not stated i ]. [Extracted from the article]

A 26-year-old woman developed hallucinations and amnesia and during treatment with dexamethasone for panniculitis-like T-cell lymphoma and haemophagocytic syndrome. Later, she was diagnosed with panniculitis-like T-cell lymphoma with haemophagocytic syndrome and started receiving oral dexamethasone 12 mg/day. Within one week, hemophagocytic syndrome had resolved; however, she developed steroid induced amnesia and hallucinations. [Extracted from the article]

A 69-year-old man developed transient global amnesia following administration of sildenafil for erectile dysfunction. B Author comment: b I "Among the neurological side effects [of sildenafil], amnestic syndrome in form a transient global amnesia (TGA) has been only rarely reported". i 1 Finsterer J. Transient global amnesia associated with sildenafil use. [Extracted from the article]

The article presents a case study of 49-year-old man having transient global amnesia and transient cortical blindness.

The article presents a case study of a 29-year-old man who developed drug toxicity, restlessness and anterograde amnesia with sleepiness leading to car accident after zolpidem abuse. He developed zolpidem dependence which is being followed by withdrawal symptom of dysarthria, agitation and terrible nightmares due to irritability and excessive tension.

The article presents a case study of a 64-year-old woman, who developed global amnesia during treatment with baclofen.

The article describes the case of eight clinical patients and six legal cases, eight men and six women, aged 28-65 years, who all developed amnesia of 3-5 hours duration with daytime automatism or somnambulisms following ingestion of zolpidem for insomnia, headache and panic attacks.

The article describes the case of a man who developed global amnesia after receiving treatment with tadalafil for impotence.

The article presents a case study of a 56-year-old woman who became amnesia while treated with ziconotide for chronic phantom pain syndrome.

The article describes the case of transient global amnesia that developed in a 54-year-old woman following administration of dobutamine and atropine for cardiac stress test.

The article presents case studies of patients who developed sleep-related complex behaviour with sleep driving and anterograde amnesia after treatment with zolpidem and doxepin.

This article discusses a case report on an 82-year-old woman who developed visual hallucinations and amnesia after receiving fluvoxamine and zolpidem for a major depressive disorder. It references a study by S. Kito and Y. Koga in the December 2006 issue of "International Psychogeriatrics." Information is presented on the increased fluvoxamine dosage received by the patient. The role played by a possible drug interaction in the patient's visual hallucinations and amnesia is discussed.

The article describes the case of mania with psychotic features that developed in a 34-year-old male patient following treatment with propolis for amnesia.

An abstract of the article "Compulsive versifying after treatment of transient epileptic amnesia," by I. O. C. Woollacott and colleagues is presented.

The article describes case studies of amnesia that developed in 16 men aged 20 to 50 years due to involuntary intoxication following poisoning with flunitrazepam.

The article presents a case study of a woman who experienced acute global amnesia after treated with methylprednisolone for multiple sclerosis (MS) relapse instances.

The article presents a case study of a 38-year-old man who developed amnesia automatism syndrome due to intoxication with bromazepam following a marital dispute.

The article describes the case of a 32-year-old man with chronic zopiclone dependence who developed retrograde amnesia and somnambulism.

The article describes the case of an adult man who developed transient global amnesia and thrombocytopenia after receiving heparin.

The article describes the case of a 39-year-old woman who developed transient, global amnesia while being treated with sibutramine for weight reduction.

The article describes the case of a 50-year-old man who acquired status epilepticus and retrograde amnesia following treatment with bupropion.

The article describes the case of a 71-year-old man with macular oedema who developed transient global amnesia after taking intravitreal bevacizumab. Decreased visual acuity in the patient's left eye developed and ophthalmoscopy revealed pigment epithelial detachment and macular oedema in the affected eye. Treatment with the drug affected the man's short-term memory, which gradually improved after three hours.

The article describes the case of a 71-year-old woman who acquired a sleep-related eating disorder while undergoing lithium treatment for cluster headache. She experienced headaches, sleepwalking, and hyperphagia with amnesia. She also had mild intimal stenosis based on ultrasonographic examination of her neck vessels.

The article describes the case of a 22-year-old man who developed abulia, cognition disorders, supraventricular tachycardia and myopathic changes in heart and skeletal muscles after a fampridine overdose. He manifested agitated behaviour after ingesting several tablets of fampridine. Diffuse hypokinesis was detected via transthoracic echocardiogram, while profound amnesia was detected via a neuropsychiatric evaluation.

The article describes the case of an adult woman who developed amnesia after receiving zolpidem. The patient experienced a total absence of recall of a long discussion with her boyfriend. Testing conducted during an ambulatory psychiatric session confirmed her amnesia. The discussion occurred around 45 minutes after the intake of the drug.

The article presents the case of a 21-year-old man who developed functional amnesic syndrome while undergoing midazolam treatment for sedation in wisdom tooth extraction. The patient, who received intravenous (IV) midazolam for the extraction, did not recover well after the operation and could not recall his girlfriend. After being discharged he presented with more memory loss and was reported to act like a 10-year-old.

The article discusses cases of two patients who developed dizziness, slurred speech, amnesia and transient nephropathy following treatment with ioversol, gentamicin and diuretics. The first patient was a 13-year-old with Tetralogy of Fallot with pulmonary atresia, who experienced dizziness, slurred speech and amnesia after receiving ioversol. The other patient was a 1-day-old neonate with critical pulmonary valve stenosis.

The article presents a case study of a 23-year-old man with a medical background of opioid dependence who experienced dependence and nocturnal amnesia while taking carisoprodol. When he stopped opioid abuse, he presented for carisoprodol abuse and new onset of norturnal blackouts. He also showed prominent tolerance, craving and salience, consistent with dependence.

The article describes the case of a woman who developed reversible retrograde amnesia after being administered analgesia with intravenous pethidine for lower back pain. She was given oxygen and isotonic saline and pethidine was discontinued. Her amnesia and disorientation resolved and she was discharged.

The article describes the case of a 23-year-old woman who developed transient environmental dependency syndrome while receiving phendimetrazine for weight loss. The patient started receiving phendimetrazine and five months after initiation of phendimetrazine, the woman was found in a stranger's home cleaning and tidying. The woman had retrograde amnesia for the entire event. She abruptly discontinued the medication of her own accord.

The article describes the case of a 43-year-old woman who experienced absence seizures after taking pregabalin for idiopathic facial pain. The patient, who had been diagnosed with absence seizures as a child, had been seizure free without treatment for 18 years. On the first day in hospital, she exhibited frequent episodes of confusion that were associated with behavior troubles and anterograde amnesia. Her EEG symptoms improved after taking valproic acid.

The article describes the cases of three women who experienced anterograde amnesia after receiving scopolamine butylbromide before undergoing gastrointestinal endoscopy. It references a study by H. Lee and colleagues published in the July 28, 2007 issue of the "World Journal of Gastroenterology." The women received scopolamine butylbromide as an antispasmodic agent minutes before undergoing gastrointestinal endoscopy.

The article describes the case of a woman who developed malignant hypertension and experienced a stroke during treatment with vitamin D for an erroneous diagnosis of hypoparathyroidism. The patient experienced a significant decrease in mental status with confusion, personality changes and amnesia. It was decided to discontinue vitamin D and calcium carbonate and the woman gradually improved and her symptoms completely resolved.

The article cites the cases of five patients who developed amnesia and consciousness disorders after receiving tetryzoline. This report did not contain sufficient CIOMS data for a Reactions summary. A search of AdisBase, Medline and the WHO Adverse Drug Reactions database did not reveal any previous case reports of amnesia associated with tetryzoline.